NK cell-based cancer immunotherapies

September 2022

About this episode

In our second episode of the “Immuno Oncology Talks”, Associate Professor Evren Alici, from the Karolinska Institutet in Sweden, was invited to discuss NK cell-based cancer immunotherapies, accompanied by his colleague Professor Hans-Gustaf Ljunggren. The primary focus of Professor Alici´s research is on novel NK cell-based therapies, and includes generation and testing of genetically engineered NK cells, like chimeric receptor and CAR-NK cells. Associate Professor Alici is also co-director of the NExtGenNK Competence center (https://ki.se/en/research/nextgennk).


Related material

All episodes

Aristi Fernandes

Suggestions on future topics and experts?

Do you have suggestions on topics or experts you would like to be featured in the podcast?

Feel free to contact me - Aristi Fernandes, PhD. Medical Lead Oncology, North Europe

About the Immuno Oncology Talks Podcast

The “Immuno Oncology Talks” aims to shed light on cutting edge science that is evolving with new immunological therapeutic approaches for the treatment of cancers. The podcasts consist of discussions with leading experts and are intended for anyone that would like to broaden their knowledge of what is happening in this rapidly expanding field.